Direxion Daily S&P Biotech Bull 3X ETF
LABU
24 hedge funds and large institutions have $25.5M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2021 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 9 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 6
0.11% less ownership
Funds ownership: 0.28% → 0.17% (-0.11%)
14% less funds holding
Funds holding: 28 → 24 (-4)
25% less call options, than puts
Call options by funds: $108M | Put options by funds: $144M
28% less capital invested
Capital invested by funds: $35.5M → $25.5M (-$10.1M)
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$5.35M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.71M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$1.22M |
| 4 |
UMC
United Maritime Capital
New York
|
+$1.18M |
| 5 |
Morgan Stanley
New York
|
+$570K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$4.44M |
| 2 |
HJMC
Hellman Jordan Management Company
Quincy,
Massachusetts
|
-$3.95M |
| 3 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$3.27M |
| 4 |
CM
Condire Management
Dallas,
Texas
|
-$3.06M |
| 5 |
HF
HRT Financial
New York
|
-$2.34M |
LABU Hedge Fund Activity: Q2 2021 in Review
24 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q2 2021, worth a combined $25.5M — down 28% from $35.5M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of LABU and 5 opened new positions — a net loss of 4 holders — while 6 trimmed existing stakes and 9 added.
The largest buyer was Susquehanna International Group, adding an estimated $5.35M. The largest seller was Jane Street, cutting an estimated $4.44M.
- 24 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q2 2021, down from 28 in Q1 2021.
- Funds reported $25.5M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q2 2021, down 28% quarter-over-quarter.
- 5 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q2 2021 and 9 closed out, a net change of -4 holders.
- The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q2 2021 was Susquehanna International Group, an estimated $5.35M added.
- The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q2 2021 was Jane Street, an estimated $4.44M sold.
Based on aggregated 13F filings for Q2 2021.